The US Medicare agency granted inpatient new-technology add-on payments for Boston Scientific's newly acquired cerebral protection system for TAVR, Respicardia's neurostimulator for sleep apnea and Procept BioRobotics' novel resection system for benign prostatic hyperplasia. The highly selective bonus payments typically help drive adoption for the chosen new technologies.
A transcatheter aortic valve replacement embolic protection system, a sleep-apnea neurostimulator and a water-based prostate resection tool have been awarded Medicare bonus payments beginning Oct. 1.
Boston Scientific Corp.'s just-acquired Sentinel cerebral protection system for TAVR procedures was among the products to gain a new-technology...